Antituberculous activity of some aryl semicarbazone derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 15, 2004, Pages 3923-3924

  Sriram, Dharmarajan ^a   Yogeeswari, Perumal ^a   Thirumurugan, Rathinasabapathy ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Antitubercular; Aryl semicarbazones

Indexed keywords

AMINOSALICYLIC ACID; CIPROFLOXACIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; N1 (4 ACETAMIDOPHENYL) N4 (2 NITROBENZYLIDENE)SEMICARBAZONE; RIFAMPICIN; SEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG INDICATION; DRUG POTENCY; DRUG RESEARCH; DRUG SCREENING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; SEMICARBAZONES; STRUCTURE-ACTIVITY RELATIONSHIP;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 3042640435     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.05.060     Document Type: Article

References (6)

1. Dye C., Scheele S., Dolin P. JAMA. 282:1999;677
2. Ginsburg A.S., Grosset J.H., Bishai W.R. Lancet Infect. Dis. 3:2003;432
3. Alland D., Kalkut G.E., Moss A.R.N. Engl. J. Med. 330:1994;1710
4. Whalen C., Horsburgh C.R., Hom D. Am. J. Respir. Crit. Care Med. 151:1995;129
5. Yogeeswari P., Sriram D., Brahmandam A., Sridharan I., Thirumurugan R., Stables J. Med. Chem. Res. 12:2003;57
6. Collins L., Frazblau S.G. Antimicrob. Agents Chemother. 41:1997;1004